Therapeutic Options for Rosacea
Rosacea is a chronic inflammatory skin disorder that mainly affects the face, particularly the cheeks, nose, forehead, and chin. Although it is not life-threatening, it can significantly impact patients’ quality of life, self-image, and psychological well-being.
The exact cause of rosacea is not fully understood, but the following factors appear to contribute:
- Vascular abnormalities (redness and flushing)
- Immune system dysfunction
- Microorganisms such as Demodex folliculorum
- Environmental and dietary triggers
- Genetic predisposition
Conventional medical treatment includes:
1. Topical therapies such as:
- Metronidazole, which has antimicrobial and anti-inflammatory properties
- Ivermectin, which targets Demodex mites and reduces inflammation
- Brimonidine, which causes vasoconstriction and reduces transient or persistent facial redness
2. Systemic therapies such as:
- Doxycycline, which provides anti-inflammatory effects
- Isotretinoin, recommended in very severe cases
3. Laser and IPL therapies
These treatments help manage vascular dilation and persistent erythema.
The management of rosacea is multifactorial and individualized. Brimonidine, metronidazole, and ivermectin are considered key components of modern therapy, while compounded formulations containing combinations of these agents allow for a personalized, holistic, and safe therapeutic approach.
Compounded preparations represent a flexible therapeutic option, ideal for tailoring treatment to each patient’s specific needs.